DAVID PLATT
CIK 1166440 · CEO · last filed 2025-11-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
39
Lifetime Open-Market Net
$230
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (PRW) Delisted | Chairman & CEO | 1,000 | — | — | $230 | 4 | 2008-09-22 |
Recent Filings · Page 2 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-16 | — | Disp (D) | +455,669 | $456 | |
| 2022-05-13 | — | Gift (G) | — | $0 | |
| 2022-01-18 | — | Mixed | −1,133,225 | -$437.7K | |
| 2021-06-07 | — | Other (J) | +2,973,988 | $386.6K | |
| 2021-01-19 | — | Grant (A) | +227,800 | $54.7K | |
| 2020-01-07 | — | Gift (G) | −864,700 | -$865 | |
| 2015-05-18 | — | Buy (P) | +6,000 | $748 | |
| 2015-03-10 | — | Buy (P) | +10,000 | $2.2K | |
| 2015-02-19 | — | Buy (P) | +250 | $145 | |
| 2015-02-13 | — | Buy (P) | +250 | $128 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.